NRXP logo

NRx Pharmaceuticals (NRXP) Operating Profit

NRXP Annual Operating Profit

-$27.84 M
+$16.50 M+37.21%

31 December 2023

NRXP Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NRXP Quarterly Operating Profit

-$3.02 M
+$4.03 M+57.13%

30 September 2024

NRXP Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NRXP TTM Operating Profit

-$20.48 M
+$2.79 M+11.98%

30 September 2024

NRXP TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NRXP Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.2%+49.6%+16.1%
3 y3 years+45.8%+66.9%+76.6%
5 y5 years+45.8%+41.3%-305.9%

NRXP Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+76.0%at high+94.3%at high+82.3%
5 y5-yearat high+76.0%-2983.6%+94.3%<-9999.0%+82.3%
alltimeall timeat high+76.0%-2983.6%+94.3%<-9999.0%+82.3%

NRx Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$3.02 M(-57.1%)
-$20.48 M(-12.0%)
June 2024
-
-$7.05 M(+17.5%)
-$23.26 M(-4.7%)
Mar 2024
-
-$6.00 M(+36.1%)
-$24.40 M(-12.3%)
Dec 2023
-$27.84 M(-37.2%)
-$4.41 M(-24.1%)
-$27.84 M(-16.5%)
Sept 2023
-
-$5.81 M(-29.1%)
-$33.32 M(-9.1%)
June 2023
-
-$8.19 M(-13.2%)
-$36.65 M(-3.7%)
Mar 2023
-
-$9.44 M(-4.6%)
-$38.06 M(-14.1%)
Dec 2022
-$44.34 M
-$9.89 M(+8.2%)
-$44.33 M(-49.3%)
Sept 2022
-
-$9.14 M(-4.8%)
-$87.42 M(-11.1%)
DateAnnualQuarterlyTTM
June 2022
-
-$9.60 M(-38.9%)
-$98.38 M(-7.1%)
Mar 2022
-
-$15.71 M(-70.4%)
-$105.90 M(-8.5%)
Dec 2021
-$115.80 M(+125.3%)
-$52.98 M(+163.6%)
-$115.80 M(+7.3%)
Sept 2021
-
-$20.10 M(+17.4%)
-$107.94 M(+16.1%)
June 2021
-
-$17.12 M(-33.1%)
-$92.99 M(+22.7%)
Mar 2021
-
-$25.61 M(-43.3%)
-$75.77 M(+51.0%)
Dec 2020
-$51.39 M
-$45.12 M(+776.3%)
-$50.17 M(+894.5%)
Sept 2020
-
-$5.15 M(-5013.4%)
-$5.04 M(-4913.4%)
June 2020
-
$104.80 K
$104.80 K

FAQ

  • What is NRx Pharmaceuticals annual operaing income?
  • What is the all time high annual operating profit for NRx Pharmaceuticals?
  • What is NRx Pharmaceuticals annual operating profit year-on-year change?
  • What is NRx Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for NRx Pharmaceuticals?
  • What is NRx Pharmaceuticals quarterly operating profit year-on-year change?
  • What is NRx Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for NRx Pharmaceuticals?
  • What is NRx Pharmaceuticals TTM operating profit year-on-year change?

What is NRx Pharmaceuticals annual operaing income?

The current annual operating profit of NRXP is -$27.84 M

What is the all time high annual operating profit for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high annual operaing income is -$27.84 M

What is NRx Pharmaceuticals annual operating profit year-on-year change?

Over the past year, NRXP annual operaing income has changed by +$16.50 M (+37.21%)

What is NRx Pharmaceuticals quarterly operating income?

The current quarterly operating profit of NRXP is -$3.02 M

What is the all time high quarterly operating profit for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high quarterly operating income is $104.80 K

What is NRx Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, NRXP quarterly operating income has changed by +$2.98 M (+49.62%)

What is NRx Pharmaceuticals TTM operating income?

The current TTM operating profit of NRXP is -$20.48 M

What is the all time high TTM operating profit for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high TTM operating income is $104.80 K

What is NRx Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, NRXP TTM operating income has changed by +$3.92 M (+16.08%)